Renal cell carcinoma: a clinicopathological follow-up study after radical nephrectomy. 2007

Dragomir P Zubac, and Leif Bostad, and Charlotta Gestblom, and Björn Kihl, and Tomas Seidal, and Tore Wentzel-Larsen, and August M Bakke
Section of Urology, Department of Surgery, The Gade Institute, Haukeland University Hospital, Bergen, Norway. dragomir.zubac@haukeland.no

OBJECTIVE To examine the prognostic significance of performance status, tumour stage, histological subtype, nuclear grade and histological tumour necrosis (HTN) in a population of consecutive patients subjected to radical nephrectomy for renal cell carcinoma (RCC). METHODS The cohort consisted of 110 males and 86 females with a mean age of 66 years (range 39-88 years). The Eastern Cooperative Oncology Group performance status (ECOG PS) was determined in all cases. The tumours were staged according to the 2002 TNM classification of the American Joint Committee on Cancer. Histological subtype was diagnosed using the Heidelberg classification. Nuclear grading was performed by means of Fuhrman's method. The median follow-up period was 65 months (mean 83 months; range 1-232 months). RESULTS Median overall survival (OS) was 65 months and median cancer-specific survival (CSS) was 171 months. CSS was correlated with TNM classification, with the longest survival occurring for stage I and II tumours, shorter survival for stage III tumours and shortest survival for stage IV tumours (p<0.001). A significant difference in CSS was found between T1N0M0 and T2N0M0 tumours (p<0.01). A 15-year CSS of 100% was revealed in patients with tumours </=4 cm in size. There was a significant difference in CSS between low nuclear grade (NG; 1+2) and high NG (3+4) tumours (p<0.001). HTN and ECOG PS were found to be independent prognostic factors (p<0.01). CONCLUSIONS ECOG PS, TNM stage, nuclear grade and tumour necrosis were found to be independent prognostic factors for survival.

UI MeSH Term Description Entries
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D009392 Nephrectomy Excision of kidney. Heminephrectomy,Heminephrectomies,Nephrectomies
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002292 Carcinoma, Renal Cell A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. Adenocarcinoma, Renal Cell,Carcinoma, Hypernephroid,Grawitz Tumor,Hypernephroma,Renal Carcinoma,Adenocarcinoma Of Kidney,Adenocarcinoma, Renal,Chromophil Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Clear Cell Renal Carcinoma,Clear Cell Renal Cell Carcinoma,Collecting Duct Carcinoma,Collecting Duct Carcinoma (Kidney),Collecting Duct Carcinoma of the Kidney,Nephroid Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma, Papillary,Renal Collecting Duct Carcinoma,Sarcomatoid Renal Cell Carcinoma,Adenocarcinoma Of Kidneys,Adenocarcinomas, Renal Cell,Cancer, Renal Cell,Carcinoma, Collecting Duct,Carcinoma, Collecting Duct (Kidney),Carcinoma, Nephroid,Carcinoma, Renal,Carcinomas, Collecting Duct,Carcinomas, Collecting Duct (Kidney),Carcinomas, Renal Cell,Collecting Duct Carcinomas,Collecting Duct Carcinomas (Kidney),Hypernephroid Carcinoma,Hypernephroid Carcinomas,Hypernephromas,Kidney, Adenocarcinoma Of,Nephroid Carcinomas,Renal Adenocarcinoma,Renal Adenocarcinomas,Renal Carcinomas,Renal Cell Adenocarcinoma,Renal Cell Adenocarcinomas,Renal Cell Cancers,Renal Cell Carcinomas,Tumor, Grawitz
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

Dragomir P Zubac, and Leif Bostad, and Charlotta Gestblom, and Björn Kihl, and Tomas Seidal, and Tore Wentzel-Larsen, and August M Bakke
May 1977, Urology,
Dragomir P Zubac, and Leif Bostad, and Charlotta Gestblom, and Björn Kihl, and Tomas Seidal, and Tore Wentzel-Larsen, and August M Bakke
June 2000, Journal of endourology,
Dragomir P Zubac, and Leif Bostad, and Charlotta Gestblom, and Björn Kihl, and Tomas Seidal, and Tore Wentzel-Larsen, and August M Bakke
February 2009, Canadian Urological Association journal = Journal de l'Association des urologues du Canada,
Dragomir P Zubac, and Leif Bostad, and Charlotta Gestblom, and Björn Kihl, and Tomas Seidal, and Tore Wentzel-Larsen, and August M Bakke
June 2007, European urology,
Dragomir P Zubac, and Leif Bostad, and Charlotta Gestblom, and Björn Kihl, and Tomas Seidal, and Tore Wentzel-Larsen, and August M Bakke
November 1994, The Urologic clinics of North America,
Dragomir P Zubac, and Leif Bostad, and Charlotta Gestblom, and Björn Kihl, and Tomas Seidal, and Tore Wentzel-Larsen, and August M Bakke
April 2016, BJU international,
Dragomir P Zubac, and Leif Bostad, and Charlotta Gestblom, and Björn Kihl, and Tomas Seidal, and Tore Wentzel-Larsen, and August M Bakke
September 1999, BJU international,
Dragomir P Zubac, and Leif Bostad, and Charlotta Gestblom, and Björn Kihl, and Tomas Seidal, and Tore Wentzel-Larsen, and August M Bakke
February 2017, The Journal of urology,
Dragomir P Zubac, and Leif Bostad, and Charlotta Gestblom, and Björn Kihl, and Tomas Seidal, and Tore Wentzel-Larsen, and August M Bakke
August 2016, The Journal of urology,
Dragomir P Zubac, and Leif Bostad, and Charlotta Gestblom, and Björn Kihl, and Tomas Seidal, and Tore Wentzel-Larsen, and August M Bakke
January 1998, European urology,
Copied contents to your clipboard!